United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,355,700 | 1,251,500 | 1,207,700 | 1,107,700 | 1,067,300 |
| Marketable Securities | 1,615,800 | 1,456,300 | 1,786,400 | 1,767,800 | 1,611,700 |
| Receivables | 290,700 | 307,300 | 278,900 | 258,600 | 272,700 |
| Inventories | 136,500 | 120,200 | 111,800 | 104,300 | 103,300 |
| Other current assets | 220,800 | 113,400 | 166,200 | 220,500 | 158,400 |
| TOTAL | $3,619,500 | $3,248,700 | $3,551,000 | $3,458,900 | $3,213,400 |
| Non-Current Assets | |||||
| PPE Net | 1,094,600 | 1,074,000 | 1,045,400 | 992,200 | 938,900 |
| Investments And Advances | 1,330,400 | 1,491,900 | 1,909,800 | 2,060,800 | 2,023,600 |
| Other Non-Current Assets | 678,700 | 680,600 | 660,800 | 511,700 | 505,400 |
| TOTAL | $3,103,700 | $3,246,500 | $3,616,000 | $3,564,700 | $3,467,900 |
| Total Assets | $6,723,200 | $6,495,200 | $7,167,000 | $7,023,600 | $6,681,300 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 400,000 | 400,000 | 400,000 | 300,000 | N/A |
| Accounts payable and accrued liabilities | 325,300 | 305,100 | 298,000 | 333,400 | 292,000 |
| Other current liabilities | 107,000 | 155,500 | 106,400 | 110,700 | 78,300 |
| TOTAL | $832,300 | $860,600 | $804,400 | $744,100 | $370,300 |
| Non-Current Liabilities | |||||
| Long Term Debt | 100,000 | 200,000 | 300,000 | 500,000 | 800,000 |
| Other Non-Current Liabilities | 93,700 | 96,500 | 77,800 | 67,400 | 100,000 |
| TOTAL | $193,700 | $296,500 | $377,800 | $567,400 | $900,000 |
| Total Liabilities | $1,026,000 | $1,157,100 | $1,182,200 | $1,311,500 | $1,270,300 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 44,491 | 44,356 | 47,059 | 46,994 | 46,933 |
| Common Shares | 700 | 700 | 700 | 700 | 700 |
| Retained earnings | 6,611,800 | 6,333,700 | 6,027,100 | 5,810,000 | 5,542,400 |
| Other shareholders' equity | -14,400 | -15,700 | -13,000 | -43,900 | -50,800 |
| TOTAL | $5,697,200 | $5,338,100 | $5,984,800 | $5,712,100 | $5,411,000 |
| Total Liabilities And Equity | $6,723,200 | $6,495,200 | $7,167,000 | $7,023,600 | $6,681,300 |